Co., Ltd. Class H ( ($HK:2235) ) has issued an update. MicroTech Medical (Hangzhou) Co., Ltd. announced that its LinX ...
Rarer diabetes patients in Singapore can now receive up to 80% government subsidies for continuous glucose monitoring (CGM) ...
Arrangements provide increased near-term funding and extend maturity of credit agreement to early 2027- Equity settlement mechanisms also ...
MiniMed’s flagship product is the MiniMed 780G automated insulin delivery system, which uses the company’s SmartGuard dosing algorithm to automatically adjust insulin delivery every five minutes based ...
DexCom Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy in 2026. On December 2, Morgan Stanley upgraded DexCom to ...
SIGN UP FOR THE AT: https://www.ktmc.com/new-cases/dexcom-inc-1?utm_source=NewMediaWire&mktm=PR ...
Medtronic plc (MDT) filed a registration statement with the U.S. Securities and Exchange Commission for an initial public offering of its diabetes business, which will operate under the name MiniMed, ...
TipRanks on MSN
Trinity Biotech Accelerates Global Rollout of High-Capacity HbA1c Column System After New Regulatory Clearances
Trinity Biotech ( (TRIB) ) just unveiled an update.
Maintaining sterile packaging for CGMs is critical to patient safety. Explore advanced methods like vacuum decay and airborne ...
Home medical equipment (HME) providers say the Center for Medicare & Medicaid Services (CMS) is ignoring what’s best for Medicare beneficiaries by finalizing its competitive ...
ReShonda Young’s Affordable Care Act health insurance helped pay for testing and diagnosis of her breast cancer last year.
Zacks Investment Research on MSN
Why DexCom (DXCM) is a top growth stock for the long term
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results